Annals of OncologyVolume 32, Supplement 5, September 2021, Page S11571633P Why do cancer clinical trials (CT) discontinue prematurely in the era of COVID-19?Author links open overlay panelG.M. Iannantuono 1, F. Torino 1, L. Strigari 2, B. Capotondi 1, F. Dell'Aria 1, V. Flaminio 1, S. Guerriero 1, G. Parisi 1, R. Rosenfeld 1, F. Amodio 1, B. Creso 1, L. Filomeno 1, F. Mastrobattista 1, A. Meacci 1, F.E. Palumbo 1, L. Santurri 1, S. Sganga 1, M. Roselli 1Show moreShareCitehttps://doi.org/10.1016/j.annonc.2021.08.1626Get rights and contentUnder an Elsevier user licenseopen archivePrevious article in issueNext article in issueRecommended articlesCited by (0)Copyright © 2021 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved.